National Institutes of Health: News and Events: NIAID Describes Research Priorities to Fight Drug-Resistant Tuberculosis

FindArticles > National Institutes of Health: News and Events > April 22, 2008 > Article > Print friendly

NIAID Describes Research Priorities to Fight Drug-Resistant Tuberculosis

<?xml version="1.0" encoding="ISO-8859-1"?>

<!DOCTYPE text PUBLIC "-//The Gale Group//DTD Mercury Version 1.0//EN" "Article.dtd">

<Text rich="yes"> <P> Tuberculosis (TB) has long been one of the world ' s great killers. Now, forms of drug-resistant TB-multidrug (MDR) and extensively drug-resistant (XDR)-are occurring at an ominous and accelerating rate. To help in the fight against drug-resistant TB, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has formulated an MDR and XDR TB research agenda. </P> <XEB.p> To read the full text of this article, click here: <XEB.a href="http://www.nih.gov/news/health/apr2008/niaid-22.htm" style="external"> http://www.nih.gov/news/health/apr2008/niaid-22.htm </XEB.a> </XEB.p> </Text>